Log In
BCIQ
Print this Print this
 

Staccato zaleplon (AZ-007)

  Manage Alerts
Collapse Summary General Information
Company Grupo Ferrer Internacional S.A.
DescriptionZaleplon delivered via Staccato system inhaler
Molecular Target GABA receptor
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationInsomnia
Indication DetailsTreat insomnia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today